Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly’s Verzenios recommended by NICE as combination therapy for early-stage breast cancer

Eli Lilly’s Verzenios recommended by NICE as combination therapy for early-stage breast cancer

Eli Lilly’s Verzenios (abemaciclib) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment for early-stage breast cancer in combination with endocrine therapy. ... The NICE approval of Verzenios in

Latest news

More from news
Approximately 420 fully matching, plus 838 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 12 fully matching, plus 134 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 57 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....